| Field | Row 1 |
|---|---|
| adsh | 0001759655-25-000050 |
| cik | 1759655 |
| name | PRIVIA HEALTH GROUP, INC. |
| sic | 8000 |
| countryba | US |
| stprba | VA |
| cityba | ARLINGTON |
| zipba | 22203 |
| bas1 | 950 N. GLEBE RD., SUITE 700 |
| bas2 | |
| baph | 571-366-8850 |
| countryma | US |
| stprma | VA |
| cityma | ARLINGTON |
| zipma | 22203 |
| mas1 | 950 N. GLEBE RD., SUITE 700 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | PH GROUP PARENT CORP. |
| changed | 20181120 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 09:02:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | prva-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001759655-25-000050 | 20250331 | Additional Paid In Capital | 833231000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Assets | 1183538000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Assets Current | 13100000.0000 | USD | 0 | us-gaap/2024 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; Counterparty Name= P M G West Texas And P M G T N; | ||
| 0001759655-25-000050 | 20250331 | Assets Noncurrent | 297071000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20210331 | Common Stock Shares Authorized | 10278581.0000 | shares | 0 | us-gaap/2024 | Plan Name= Omnibus Incentive Plan; | ||
| 0001759655-25-000050 | 20241231 | Common Stock Shares Outstanding | 120309346.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20250331 | Common Stock Shares Outstanding | 121391314.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | General And Administrative Expense | 31721000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 3807000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease In Accounts Payable | -7180000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease In Accounts Receivable | 55320000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Net Cash Provided By Used In Operating Activities | -33137000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Nonoperating Income Expense | 2931000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Income Loss | 4200000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001759655-25-000050 | 20241231 | Operating Lease Liability Noncurrent | 3037000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Lease Liability Noncurrent | 3049000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250430 | Payments To Acquire Businesses Net Of Cash Acquired | 95000000.0000 | USD | 0 | us-gaap/2024 | Business Acquisition= Multi Specialty Practice; Subsequent Event Type= Subsequent Event; | ||
| 0001759655-25-000050 | 20250331 | Retained Earnings Accumulated Deficit | -175009000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 415243000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 274823000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= F F S Patient Care; | ||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 480097000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 46024000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 48264000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -179229000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1214000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 50090000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2243000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Stock Issued During Period Value Share Based Compensation | 11000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 11904000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 17790000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20240331 | Amortization Of Intangible Assets | 1527000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -38375000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Depreciation | 228000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Depreciation Depletion And Amortization | 1901000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liabilities And Stockholders Equity | 1135783000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liabilities Current | 449146000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 400288000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Income Loss | 5218000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Other Liabilities Noncurrent | 153000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Profit Loss | 3056000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Profit Loss | 2984000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20241231 | Property Plant And Equipment Net | 1242000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 70690000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Capitated Revenue; | ||
| 0001759655-25-000050 | 20240331 | Selling And Marketing Expense | 6085000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Share Based Compensation | 11904000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Stockholders Equity | 635183000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 45952000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 766243000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -190630000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 125053404.0000 | shares | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 120623670.0000 | shares | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 469331000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Accounts Payable And Accrued Liabilities Current | 81986000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 17790000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20241231 | Assets Current | 12100000.0000 | USD | 0 | us-gaap/2024 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; Counterparty Name= P M G West Texas And P M G T N; | ||
| 0001759655-25-000050 | 20241231 | Cash And Cash Equivalents At Carrying Value | 491149000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001759655-25-000050 | 20250331 | Common Stock Shares Authorized | 1000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Common Stock Value | 1203000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Earnings Per Share Diluted | 0.0300 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Income Tax Expense Benefit | 2103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease In Accounts Payable | -13850000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 914000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liabilities | 474012000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liabilities Noncurrent | 3190000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liabilities Noncurrent | 3202000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Net Income Loss | 2984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Net Income Loss | 4220000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | 72000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Operating Income Loss | 823000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Other Liabilities Noncurrent | 153000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Payments To Acquire Businesses Net Of Cash Acquired | 707000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Payments To Acquire Businesses Net Of Cash Acquired | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Prepaid Expense And Other Assets Current | 28409000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Profit Loss | 72000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20240331 | Profit Loss | 2984000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 15201000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Care Management Fee P M P M; | ||
| 0001759655-25-000050 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2232000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20250331 | Stock Issued During Period Value Share Based Compensation | 2243000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20250331 | Accounts Receivable Net Current | 388727000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 17790000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Assets Current | 886467000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Cash And Cash Equivalents At Carrying Value | 469331000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 491149000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Cost Of Platform | 59526000.0000 | USD | 1 | 0001759655-25-000050 | |||
| 0001759655-25-000050 | 20250331 | Deferred Income Tax Assets Net | 24670000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Deferred Income Tax Expense Benefit | 863000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Depreciation Depletion And Amortization | 1821000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Earnings Per Share Basic | 0.0300 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Finite Lived Intangible Assets Net | 108134000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Goodwill | 141615000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Income Taxes Paid Net | -313000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease In Operating Lease Liability | -155000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease In Other Noncurrent Assets | -275000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liabilities Current | 12100000.0000 | USD | 0 | us-gaap/2024 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; Counterparty Name= P M G West Texas And P M G T N; | ||
| 0001759655-25-000050 | 20250331 | Liability For Future Policy Benefits Period Expense | 374809000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Minority Interest | 48264000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | 1826000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Operating Income Loss | 3000000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001759655-25-000050 | 20240331 | Payments For Proceeds From Other Investing Activities | 5006000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Proceeds From Stock Options Exercised | 475000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Proceeds From Stock Options Exercised | 2243000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Retained Earnings Accumulated Deficit | -179229000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 47464000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Shared Savings; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity | 659436000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 753869000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 833231000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20250331 | Accounts Payable And Accrued Liabilities Current | 68136000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 351136000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -21818000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001759655-25-000050 | 20250331 | Common Stock Shares Issued | 121391314.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Common Stock Shares Outstanding | 118216979.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Cost Of Platform | 54057000.0000 | USD | 1 | 0001759655-25-000050 | |||
| 0001759655-25-000050 | 20250331 | Earnings Per Share Basic | 0.0300 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Goodwill | 141615000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 8149000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Net Cash Provided By Used In Investing Activities | -5713000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Expenses | 474879000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Lease Liability Current | 2386000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Operating Lease Right Of Use Asset | 4719000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Prepaid Expense And Other Assets Current | 27495000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Profit Loss | 6046000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Profit Loss | 1826000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Noncontrolling Interest; | ||
| 0001759655-25-000050 | 20250331 | Property Plant And Equipment Net | 1014000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 32255000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= F F S Administrative Services; | ||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 47912000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Shared Savings; | ||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 607389000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1182000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 683447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 709526000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Stock Issued During Period Value Share Based Compensation | 475000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 127752527.0000 | shares | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Accounts Receivable Net Current | 316179000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Assets | 1135783000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Deferred Income Tax Assets Net | 26383000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Deferred Income Tax Expense Benefit | 1713000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Depreciation | 294000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Earnings Per Share Diluted | 0.0200 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Income Taxes Paid Net | -230000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease In Accounts Receivable | 72548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 10391000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease Physician And Practice Liability | 24208000.0000 | USD | 1 | 0001759655-25-000050 | |||
| 0001759655-25-000050 | 20240331 | Interest Paid Net | 93000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Net Cash Provided By Used In Financing Activities | 2243000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Operating Lease Right Of Use Asset | 4828000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Other Assets Noncurrent | 16919000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Profit Loss | 4220000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 51304000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Capitated Revenue; | ||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 10603000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Care Management Fee P M P M; | ||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 29076000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= F F S Administrative Services; | ||
| 0001759655-25-000050 | 20250331 | Selling And Marketing Expense | 6922000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Share Based Compensation | 17790000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -193614000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1203000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 635183000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20240331 | Stock Issued During Period Value Share Based Compensation | 5000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Stock Issued During Period Value Share Based Compensation | 475000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20241231 | Common Stock Shares Authorized | 1000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Income Tax Expense Benefit | 751000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liabilities | 452336000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liabilities And Stockholders Equity | 1183538000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liabilities Current | 470810000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Liabilities Current | 13100000.0000 | USD | 0 | us-gaap/2024 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; Counterparty Name= P M G West Texas And P M G T N; | ||
| 0001759655-25-000050 | 20240331 | Liability For Future Policy Benefits Period Expense | 320336000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 364607000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 66355000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= At Risk Capitation Arrangements; | ||
| 0001759655-25-000050 | 20250331 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 86361000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= At Risk Capitation Arrangements; | ||
| 0001759655-25-000050 | 20241231 | Operating Lease Liability Current | 2553000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Payments For Proceeds From Other Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Profit Loss | 4220000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 311761000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= F F S Patient Care; | ||
| 0001759655-25-000050 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 2278000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenue; | ||
| 0001759655-25-000050 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 561437000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 813209000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 659436000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -175009000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001759655-25-000050 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 461923.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 118505320.0000 | shares | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Additional Paid In Capital | 813209000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 11904000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 11904000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001759655-25-000050 | 20250331 | Amortization Of Intangible Assets | 1673000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Assets Current | 834823000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Assets Noncurrent | 300960000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 389511000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Common Stock Shares Issued | 120309346.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Common Stock Shares Outstanding | 118678902.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20241231 | Common Stock Shares Outstanding | 120309346.0000 | shares | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Common Stock Shares Outstanding | 121391314.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20250331 | Common Stock Value | 1214000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Finite Lived Intangible Assets Net | 109807000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | General And Administrative Expense | 32121000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease In Operating Lease Liability | -777000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Increase Decrease In Other Noncurrent Assets | 1321000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Increase Decrease Physician And Practice Liability | 35681000.0000 | USD | 1 | 0001759655-25-000050 | |||
| 0001759655-25-000050 | 20231231 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 67138000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= At Risk Capitation Arrangements; | ||
| 0001759655-25-000050 | 20240331 | Liability For Unpaid Claims And Claims Adjustment Expense Net | 74521000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= At Risk Capitation Arrangements; | ||
| 0001759655-25-000050 | 20250331 | Minority Interest | 50090000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Net Cash Provided By Used In Financing Activities | 475000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20250331 | Net Cash Provided By Used In Operating Activities | -24061000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Nonoperating Income Expense | 2984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Operating Expenses | 414420000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20241231 | Other Assets Noncurrent | 17085000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 1973000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Revenue; | ||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 622824000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1187000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 576800000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Parent; | ||
| 0001759655-25-000050 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 1081968.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001759655-25-000050 | 20240331 | Stock Issued During Period Value Share Based Compensation | 470000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Businesses, Net of Cash Acquired | The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Liability For Future Policy Benefits Period Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Liability for Future Policy Benefits, Period Expense (Income) | Amount of expense (income) recognized due to changes in the accrued obligation to policyholders that relates to insured events. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Cost Of Platform | 0001759655-25-000050 | 1 | 0 | monetary | D | D | Cost Of Platform | Cost Of Platform |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Liability For Unpaid Claims And Claims Adjustment Expense Net | us-gaap/2024 | 0 | 0 | monetary | I | C | Liability for Unpaid Claims and Claims Adjustment Expense, Net | Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Payments For Proceeds From Other Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for (Proceeds from) Other Investing Activities | Amount of cash (inflow) outflow from investing activities classified as other. |
| Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Increase Decrease Physician And Practice Liability | 0001759655-25-000050 | 1 | 0 | monetary | D | D | Increase (Decrease) Physician And Practice Liability | Increase (Decrease) Physician And Practice Liability |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
| Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. |
| Minority Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001759655-25-000050 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001759655-25-000050 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable | 0 |
| 0001759655-25-000050 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001759655-25-000050 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001759655-25-000050 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001759655-25-000050 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating right-of-use asset | 0 |
| 0001759655-25-000050 | 2 | 10 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible assets, net | 0 |
| 0001759655-25-000050 | 2 | 11 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001759655-25-000050 | 2 | 12 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred tax asset | 0 |
| 0001759655-25-000050 | 2 | 13 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other non-current assets | 0 |
| 0001759655-25-000050 | 2 | 14 | BS | 0 | H | Assets Noncurrent | us-gaap/2024 | Total non-current assets | 0 |
| 0001759655-25-000050 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001759655-25-000050 | 2 | 18 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001759655-25-000050 | 2 | 19 | BS | 0 | H | Liability For Unpaid Claims And Claims Adjustment Expense Net | us-gaap/2024 | Provider liability | 0 |
| 0001759655-25-000050 | 2 | 20 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current | 0 |
| 0001759655-25-000050 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001759655-25-000050 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, non-current | 0 |
| 0001759655-25-000050 | 2 | 24 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
| 0001759655-25-000050 | 2 | 25 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total non-current liabilities | 0 |
| 0001759655-25-000050 | 2 | 26 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001759655-25-000050 | 2 | 27 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 9) | 0 |
| 0001759655-25-000050 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 121,391,314 and 120,309,346 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001759655-25-000050 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001759655-25-000050 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001759655-25-000050 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Privia Health Group, Inc. stockholders equity | 0 |
| 0001759655-25-000050 | 2 | 33 | BS | 0 | H | Minority Interest | us-gaap/2024 | Non-controlling interest | 0 |
| 0001759655-25-000050 | 2 | 34 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Total stockholders equity | 0 |
| 0001759655-25-000050 | 2 | 35 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001759655-25-000050 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001759655-25-000050 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001759655-25-000050 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
| 0001759655-25-000050 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
| 0001759655-25-000050 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | Revenue | 0 |
| 0001759655-25-000050 | 4 | 3 | IS | 0 | H | Liability For Future Policy Benefits Period Expense | us-gaap/2024 | Provider expense | 0 |
| 0001759655-25-000050 | 4 | 4 | IS | 0 | H | Cost Of Platform | 0001759655-25-000050 | Cost of platform | 0 |
| 0001759655-25-000050 | 4 | 5 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Sales and marketing | 0 |
| 0001759655-25-000050 | 4 | 6 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001759655-25-000050 | 4 | 7 | IS | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001759655-25-000050 | 4 | 8 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001759655-25-000050 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating income | 0 |
| 0001759655-25-000050 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Interest income, net | 0 |
| 0001759655-25-000050 | 4 | 11 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income before provision for income taxes | 0 |
| 0001759655-25-000050 | 4 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 0 |
| 0001759655-25-000050 | 4 | 13 | IS | 0 | H | Profit Loss | us-gaap/2024 | Net income | 0 |
| 0001759655-25-000050 | 4 | 14 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2024 | Less: Net income attributable to non-controlling interests | 0 |
| 0001759655-25-000050 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income attributable to Privia Health Group, Inc. | 0 |
| 0001759655-25-000050 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share) | 0 |
| 0001759655-25-000050 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share) | 0 |
| 0001759655-25-000050 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average common shares outstanding - basic (in shares) | 0 |
| 0001759655-25-000050 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common shares outstanding diluted (in shares) | 0 |
| 0001759655-25-000050 | 5 | 11 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001759655-25-000050 | 5 | 12 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Beginning balance | 0 |
| 0001759655-25-000050 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares) | 0 |
| 0001759655-25-000050 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 0 |
| 0001759655-25-000050 | 5 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001759655-25-000050 | 5 | 16 | EQ | 0 | H | Profit Loss | us-gaap/2024 | Net income | 0 |
| 0001759655-25-000050 | 5 | 17 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001759655-25-000050 | 5 | 18 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Ending balance | 0 |
| 0001759655-25-000050 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income | 0 |
| 0001759655-25-000050 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001759655-25-000050 | 6 | 5 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangibles | 0 |
| 0001759655-25-000050 | 6 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001759655-25-000050 | 6 | 7 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Deferred tax expense | 0 |
| 0001759655-25-000050 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001759655-25-000050 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001759655-25-000050 | 6 | 11 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other non-current assets and right-of-use asset | 1 |
| 0001759655-25-000050 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001759655-25-000050 | 6 | 13 | CF | 0 | H | Increase Decrease Physician And Practice Liability | 0001759655-25-000050 | Provider liability | 0 |
| 0001759655-25-000050 | 6 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001759655-25-000050 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001759655-25-000050 | 6 | 17 | CF | 0 | H | Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2024 | Business acquisitions, net of cash acquired | 1 |
| 0001759655-25-000050 | 6 | 18 | CF | 0 | H | Payments For Proceeds From Other Investing Activities | us-gaap/2024 | Other | 1 |
| 0001759655-25-000050 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001759655-25-000050 | 6 | 21 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercised stock options | 0 |
| 0001759655-25-000050 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001759655-25-000050 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash and cash equivalents | 0 |
| 0001759655-25-000050 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001759655-25-000050 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001759655-25-000050 | 6 | 27 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
| 0001759655-25-000050 | 6 | 28 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Income tax refunds received | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |